1. Home
  2. MHH vs ATYR Comparison

MHH vs ATYR Comparison

Compare MHH & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

HOLD

Current Price

$6.96

Market Cap

82.5M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHH
ATYR
Founded
1986
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.5M
79.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MHH
ATYR
Price
$6.96
$0.73
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$8.75
AVG Volume (30 Days)
33.9K
2.0M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$196,657,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.50
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
1.24
N/A
52 Week Low
$6.20
$0.64
52 Week High
$16.00
$7.29

Technical Indicators

Market Signals
Indicator
MHH
ATYR
Relative Strength Index (RSI) 49.30 42.35
Support Level $6.79 $0.69
Resistance Level $7.75 $0.76
Average True Range (ATR) 0.50 0.04
MACD -0.01 0.01
Stochastic Oscillator 48.79 29.49

Price Performance

Historical Comparison
MHH
ATYR

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: